Method and Materials for Isolation of Nucleic Acid Materials
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 14/060,214, filed Oct 22, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,382,532 | Method and Materials for Isolation of Nucleic Acid Materials In force · Medium confidence | Neumodx Molecular, Inc. | In force | Medium confidence | ||
| US 9,540,636 | Method and Materials for Isolation of Nucleic Acid Materials In force · Low confidence | Neumodx Molecular, Inc. | In force | Low confidence | ||
| US 10,633,647 | Method and Materials for Isolation of Nucleic Acid Materials In force · Low confidence | Neumodx Molecular, Inc. | In force | Low confidence | ||
| Application 14/060,214 | Method and Materials for Isolation of Nucleic Acid Materials Abandoned Abandoned Apr 29, 2014 | Neumodx Molecular, Inc. | Abandoned | Abandoned Apr 29, 2014 | ||
| Application 16/825,126 | Method and Materials for Isolation of Nucleic Acid Materials Abandoned Abandoned Sep 30, 2022 | Neumodx Molecular, Inc. | Abandoned | Abandoned Sep 30, 2022 | ||
| Application 17/942,864 | Method and Materials for Isolation of Nucleic Acid Materials Abandoned Abandoned Apr 1, 2026 | NeuMoDx Molecular, Inc. | Abandoned | Abandoned Apr 1, 2026 |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Neumodx Molecular, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.